GENOME-WIDE ANALYSIS OF ANDROGEN RECEPTOR SPLICE VARIANTS BINDING AND GENE REGULATION IN CASTRATION-RESISTANT PROSTATE CANCER

被引：0
|
作者：
Lu, Ji
Huang, Haojie
Tindall, Donald
机构：
来源：
JOURNAL OF UROLOGY | 2014年 / 191卷 / 04期
关键词：
D O I：
10.1016/j.juro.2014.02.617
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
OP1-09
引用
收藏
页码：E165 / E165
页数：1
相关论文
共 50 条
  • [41] Androgen Receptor and Beyond, Targeting Androgen Signaling in Castration-Resistant Prostate Cancer
    Reichert, Zachery R.
    Hussain, Maha
    CANCER JOURNAL, 2016, 22 (05): : 326 - 329
  • [42] Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
    Mostaghel, Elahe A.
    Marck, Brett T.
    Plymate, Stephen R.
    Vessella, Robert L.
    Balk, Stephen
    Matsumoto, Alvin M.
    Nelson, Peter S.
    Montgomery, R. Bruce
    CLINICAL CANCER RESEARCH, 2011, 17 (18) : 5913 - 5925
  • [43] Androgen biosynthesis in castration-resistant prostate cancer
    Penning, Trevor M.
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T67 - T78
  • [44] Targeting persistent androgen receptor signaling in castration-resistant prostate cancer
    Graham, Laura
    Schweizer, Michael T.
    MEDICAL ONCOLOGY, 2016, 33 (05)
  • [45] Adaptive responses of androgen receptor signaling in castration-resistant prostate cancer
    Perner, Sven
    Cronauer, Marcus V.
    Schrader, Andres Jan
    Klocker, Helmut
    Culig, Zoran
    Baniahmad, Aria
    ONCOTARGET, 2015, 6 (34) : 35542 - 35555
  • [46] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Won Kim
    Charles J Ryan
    Current Treatment Options in Oncology, 2012, 13 : 189 - 200
  • [47] Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
    George, Daniel J.
    Morgans, Alicia K.
    Constantinovici, Niculae
    Khan, Nasreen
    Khan, Javeed
    Chen, Guifang
    Hlebec, Vlasta
    Shore, Neal D.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [48] Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
    Conteduca, Vincenza
    Jayaram, Anuradha
    Romero-Laorden, Nuria
    Wetterskog, Daniel
    Salvi, Samanta
    Gurioli, Giorgia
    Scarpi, Emanuela
    Castro, Elena
    Marin-Aguilera, Mercedes
    Lolli, Cristian
    Schepisi, Giuseppe
    Maugeri, Antonio
    Wingate, Anna
    Farolfi, Alberto
    Casadio, Valentina
    Medina, Ana
    Puente, Javier
    Mendez Vidal, Ma Jose
    Morales-Barrera, Rafael
    Villa-Guzman, Jose C.
    Hernando, Susana
    Rodriguez-Vida, Alejo
    Gonzalez-del-Alba, Aranzazu
    Mellado, Begona
    Gonzalez-Billalabeitia, Enrique
    Olmos, David
    Attard, Gerhardt
    De Giorgi, Ugo
    EUROPEAN UROLOGY, 2019, 75 (03) : 368 - 373
  • [49] Spironolactone: A selective androgen receptor modulator in castration-resistant prostate cancer
    Barthelemy, Philippe
    Erdmann, Eva
    Duclos, Brigitte
    Bergerat, Jean Pierre
    Kurtz, Jean-Emmanuel
    Ceraline, Jocelyn
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [50] Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
    Scher, HI
    Buchanan, G
    Gerald, W
    Butler, LM
    Tilley, WD
    ENDOCRINE-RELATED CANCER, 2004, 11 (03) : 459 - 476
12345